Furthermore, ribonucleotide reductase (RR) is composed of dimerized large (RRM1) and small (RRM2) subunits and regulates intracellular pools of deoxy-CTP (dCTP), the expression of which leads to tumor cell resistance to nucleoside analogs, such as Ara-C treatment [31]. This evidence concerns the gene RRM1 and neoplasm.